Zobrazeno 1 - 5
of 5
pro vyhledávání: '"A. V. Sitenkova (Bukhovets)"'
Autor:
V. R. Timergalieva, A. Yu. Sitenkov, A. V. Sitenkova (Bukhovets), E. S. Elizarova, D. S. Gordeeva, I. I. Semina, R. I. Moustafine
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 12, Iss 4, Pp 181-188 (2023)
Introduction. Orally dispersible dosage forms are one of the new trends in the field of drug delivery systems. One type of such dosage forms is oral lyophilisates that are obtained by freeze-drying a pre-prepared mixture containing the active pharmac
Externí odkaz:
https://doaj.org/article/b7d7691515fb42caa3a2e817023d6120
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 9, Iss 2, Pp 72-76 (2020)
Introduction. There are a number of drugs, the absorption zone of which is the upper region of the gastrointestinal tract (GIT) – the stomach and duodenum. To increase bioavailability, gastroretentive (intragastric) systems for the controlled drug
Externí odkaz:
https://doaj.org/article/deb2ceb46d9e454aa51314bfc6baf7fe
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 0, Iss 1, Pp 156-162 (2019)
Dissolution test plays an important role at different levels of the development and manufacturing drugs as one of the major quality control tools and an integral part of In vitro tests in the study of drug release from the developed dosage forms. Art
Externí odkaz:
https://doaj.org/article/aa3a6dc50d724ec0928238cc06556775
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 0, Iss 1, Pp 164-166 (2019)
The results of Indomethacin release from the oral drug delivery systems based on interpolymer complexes with Eudragit® copolymers are presented. The release assessment was performed by two methods - flow-through cell (USP IV Apparatus) and the recip
Externí odkaz:
https://doaj.org/article/71c9ac5421f645e08f7ba0f65a304cfb
Publikováno v:
Scientia Pharmaceutica, Vol 92, Iss 1, p 14 (2024)
The aim of this study was the analysis of interpolyelectrolyte complexes (IPECs) based on Eudragit® EPO and Eudragit® L100 as prospective carriers for gastroretentive drug delivery systems (GRDDS) using two model drugs: metronidazole (MZ) and acycl
Externí odkaz:
https://doaj.org/article/3f7bbd86e72c4bf0a0c7389d60d6a32e